HEADER TRANSFERASE 10-NOV-22 8BM2 TITLE CRYSTAL STRUCTURE OF JAK2 JH1 IN COMPLEX WITH GANDOTINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: JANUS KINASE 2,JAK-2; COMPND 5 EC: 2.7.10.2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK2; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS JANUS KINASE, INHIBITOR COMPLEX, JAK2, JH1, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Y.MIAO,T.HAIKARAINEN REVDAT 3 06-NOV-24 8BM2 1 REMARK REVDAT 2 10-JUL-24 8BM2 1 JRNL REVDAT 1 22-NOV-23 8BM2 0 JRNL AUTH Y.MIAO,A.VIRTANEN,J.ZMAJKOVIC,M.HILPERT,R.C.SKODA, JRNL AUTH 2 O.SILVENNOINEN,T.HAIKARAINEN JRNL TITL FUNCTIONAL AND STRUCTURAL CHARACTERIZATION OF CLINICAL-STAGE JRNL TITL 2 JANUS KINASE 2 INHIBITORS IDENTIFIES DETERMINANTS FOR DRUG JRNL TITL 3 SELECTIVITY. JRNL REF J.MED.CHEM. V. 67 10012 2024 JRNL REFN ISSN 0022-2623 JRNL PMID 38843875 JRNL DOI 10.1021/ACS.JMEDCHEM.4C00197 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 58.46 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 118905 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.177 REMARK 3 FREE R VALUE : 0.202 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 5934 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 58.4600 - 4.6600 0.99 3864 196 0.1979 0.1987 REMARK 3 2 4.6600 - 3.7000 1.00 3804 224 0.1351 0.1535 REMARK 3 3 3.7000 - 3.2300 1.00 3795 194 0.1446 0.1368 REMARK 3 4 3.2300 - 2.9400 1.00 3791 219 0.1660 0.2040 REMARK 3 5 2.9400 - 2.7200 1.00 3776 194 0.1701 0.2315 REMARK 3 6 2.7200 - 2.5600 1.00 3754 195 0.1708 0.2155 REMARK 3 7 2.5600 - 2.4400 1.00 3831 191 0.1672 0.2082 REMARK 3 8 2.4400 - 2.3300 1.00 3718 213 0.1582 0.1880 REMARK 3 9 2.3300 - 2.2400 1.00 3789 189 0.1540 0.1867 REMARK 3 10 2.2400 - 2.1600 1.00 3747 205 0.1490 0.1674 REMARK 3 11 2.1600 - 2.1000 1.00 3792 201 0.1509 0.1921 REMARK 3 12 2.1000 - 2.0400 1.00 3753 185 0.1608 0.1905 REMARK 3 13 2.0400 - 1.9800 1.00 3767 192 0.1807 0.2211 REMARK 3 14 1.9800 - 1.9300 1.00 3751 205 0.1839 0.2084 REMARK 3 15 1.9300 - 1.8900 1.00 3776 200 0.1800 0.1995 REMARK 3 16 1.8900 - 1.8500 1.00 3766 199 0.1860 0.2125 REMARK 3 17 1.8500 - 1.8100 1.00 3739 194 0.1906 0.2106 REMARK 3 18 1.8100 - 1.7800 1.00 3730 202 0.2041 0.2402 REMARK 3 19 1.7800 - 1.7500 1.00 3766 187 0.2124 0.2528 REMARK 3 20 1.7500 - 1.7200 1.00 3784 204 0.2229 0.2662 REMARK 3 21 1.7200 - 1.6900 1.00 3748 183 0.2381 0.2774 REMARK 3 22 1.6900 - 1.6600 1.00 3779 210 0.2440 0.2711 REMARK 3 23 1.6600 - 1.6400 1.00 3685 188 0.2481 0.2756 REMARK 3 24 1.6400 - 1.6200 1.00 3798 190 0.2659 0.2851 REMARK 3 25 1.6200 - 1.5900 1.00 3788 197 0.2557 0.2792 REMARK 3 26 1.5900 - 1.5700 1.00 3741 182 0.2675 0.3373 REMARK 3 27 1.5700 - 1.5500 1.00 3727 204 0.2734 0.3114 REMARK 3 28 1.5500 - 1.5300 1.00 3758 194 0.2751 0.2994 REMARK 3 29 1.5300 - 1.5200 1.00 3806 195 0.2835 0.3137 REMARK 3 30 1.5200 - 1.5000 0.99 3648 202 0.3036 0.3025 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.167 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.904 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.016 5216 REMARK 3 ANGLE : 1.323 7061 REMARK 3 CHIRALITY : 0.100 732 REMARK 3 PLANARITY : 0.015 910 REMARK 3 DIHEDRAL : 16.118 2005 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8BM2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-NOV-22. REMARK 100 THE DEPOSITION ID IS D_1292126550. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-NOV-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97625 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 XE 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 118979 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 79.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 6.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6VN8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.7 M NA-MALONATE, 0.1 M GLY-GLY PH REMARK 280 8.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z+1/2 REMARK 290 4555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 41.62407 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.62700 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 54.51785 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 41.62407 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 34.62700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 54.51785 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1480 LIES ON A SPECIAL POSITION. REMARK 375 HOH B1526 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 816 REMARK 465 GLY A 817 REMARK 465 HIS A 818 REMARK 465 HIS A 819 REMARK 465 HIS A 820 REMARK 465 HIS A 821 REMARK 465 HIS A 822 REMARK 465 HIS A 823 REMARK 465 SER A 824 REMARK 465 SER A 825 REMARK 465 GLY A 826 REMARK 465 VAL A 827 REMARK 465 ASP A 828 REMARK 465 LEU A 829 REMARK 465 GLY A 830 REMARK 465 THR A 831 REMARK 465 GLU A 832 REMARK 465 MET B 816 REMARK 465 GLY B 817 REMARK 465 HIS B 818 REMARK 465 HIS B 819 REMARK 465 HIS B 820 REMARK 465 HIS B 821 REMARK 465 HIS B 822 REMARK 465 HIS B 823 REMARK 465 SER B 824 REMARK 465 SER B 825 REMARK 465 GLY B 826 REMARK 465 VAL B 827 REMARK 465 ASP B 828 REMARK 465 LEU B 829 REMARK 465 GLY B 830 REMARK 465 THR B 831 REMARK 465 GLU B 832 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 837 CG CD OE1 NE2 REMARK 470 GLN A 872 CG CD OE1 NE2 REMARK 470 GLU A1012 CG CD OE1 OE2 REMARK 470 LYS A1053 CG CD CE NZ REMARK 470 GLN B 837 CG CD OE1 NE2 REMARK 470 LYS B 857 CG CD CE NZ REMARK 470 ARG B 897 CG CD NE CZ NH1 NH2 REMARK 470 GLN B1003 CG CD OE1 NE2 REMARK 470 GLU B1012 CG CD OE1 OE2 REMARK 470 LYS B1053 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 1060 HH21 ARG A 1063 1.42 REMARK 500 OD1 ASP A 873 OG1 THR A 875 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 866 CB CYS A 866 SG -0.103 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 840 79.96 -110.78 REMARK 500 GLN A 872 44.67 39.29 REMARK 500 THR A 875 -147.37 -110.44 REMARK 500 ARG A 975 -1.57 72.69 REMARK 500 ASP A 976 43.05 -143.04 REMARK 500 GLU A1012 34.26 -149.93 REMARK 500 ILE A1051 44.32 30.11 REMARK 500 LYS A1053 -73.11 -37.05 REMARK 500 SER A1054 -2.29 -57.51 REMARK 500 ASN A1085 11.73 84.33 REMARK 500 TRP A1106 49.93 -85.91 REMARK 500 MET B 839 134.28 -175.42 REMARK 500 ASN B 874 14.39 59.93 REMARK 500 THR B 875 -163.40 -111.25 REMARK 500 ASP B 976 40.91 -149.19 REMARK 500 ASP B 994 71.59 50.59 REMARK 500 GLU B1012 46.64 -173.86 REMARK 500 SER B1054 -5.79 88.33 REMARK 500 TRP B1106 42.79 -88.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 923 0.11 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL DBREF 8BM2 A 840 1132 UNP O60674 JAK2_HUMAN 840 1132 DBREF 8BM2 B 840 1132 UNP O60674 JAK2_HUMAN 840 1132 SEQADV 8BM2 MET A 816 UNP O60674 INITIATING METHIONINE SEQADV 8BM2 GLY A 817 UNP O60674 EXPRESSION TAG SEQADV 8BM2 HIS A 818 UNP O60674 EXPRESSION TAG SEQADV 8BM2 HIS A 819 UNP O60674 EXPRESSION TAG SEQADV 8BM2 HIS A 820 UNP O60674 EXPRESSION TAG SEQADV 8BM2 HIS A 821 UNP O60674 EXPRESSION TAG SEQADV 8BM2 HIS A 822 UNP O60674 EXPRESSION TAG SEQADV 8BM2 HIS A 823 UNP O60674 EXPRESSION TAG SEQADV 8BM2 SER A 824 UNP O60674 EXPRESSION TAG SEQADV 8BM2 SER A 825 UNP O60674 EXPRESSION TAG SEQADV 8BM2 GLY A 826 UNP O60674 EXPRESSION TAG SEQADV 8BM2 VAL A 827 UNP O60674 EXPRESSION TAG SEQADV 8BM2 ASP A 828 UNP O60674 EXPRESSION TAG SEQADV 8BM2 LEU A 829 UNP O60674 EXPRESSION TAG SEQADV 8BM2 GLY A 830 UNP O60674 EXPRESSION TAG SEQADV 8BM2 THR A 831 UNP O60674 EXPRESSION TAG SEQADV 8BM2 GLU A 832 UNP O60674 EXPRESSION TAG SEQADV 8BM2 ASN A 833 UNP O60674 EXPRESSION TAG SEQADV 8BM2 LEU A 834 UNP O60674 EXPRESSION TAG SEQADV 8BM2 TYR A 835 UNP O60674 EXPRESSION TAG SEQADV 8BM2 PHE A 836 UNP O60674 EXPRESSION TAG SEQADV 8BM2 GLN A 837 UNP O60674 EXPRESSION TAG SEQADV 8BM2 SER A 838 UNP O60674 EXPRESSION TAG SEQADV 8BM2 MET A 839 UNP O60674 EXPRESSION TAG SEQADV 8BM2 MET B 816 UNP O60674 INITIATING METHIONINE SEQADV 8BM2 GLY B 817 UNP O60674 EXPRESSION TAG SEQADV 8BM2 HIS B 818 UNP O60674 EXPRESSION TAG SEQADV 8BM2 HIS B 819 UNP O60674 EXPRESSION TAG SEQADV 8BM2 HIS B 820 UNP O60674 EXPRESSION TAG SEQADV 8BM2 HIS B 821 UNP O60674 EXPRESSION TAG SEQADV 8BM2 HIS B 822 UNP O60674 EXPRESSION TAG SEQADV 8BM2 HIS B 823 UNP O60674 EXPRESSION TAG SEQADV 8BM2 SER B 824 UNP O60674 EXPRESSION TAG SEQADV 8BM2 SER B 825 UNP O60674 EXPRESSION TAG SEQADV 8BM2 GLY B 826 UNP O60674 EXPRESSION TAG SEQADV 8BM2 VAL B 827 UNP O60674 EXPRESSION TAG SEQADV 8BM2 ASP B 828 UNP O60674 EXPRESSION TAG SEQADV 8BM2 LEU B 829 UNP O60674 EXPRESSION TAG SEQADV 8BM2 GLY B 830 UNP O60674 EXPRESSION TAG SEQADV 8BM2 THR B 831 UNP O60674 EXPRESSION TAG SEQADV 8BM2 GLU B 832 UNP O60674 EXPRESSION TAG SEQADV 8BM2 ASN B 833 UNP O60674 EXPRESSION TAG SEQADV 8BM2 LEU B 834 UNP O60674 EXPRESSION TAG SEQADV 8BM2 TYR B 835 UNP O60674 EXPRESSION TAG SEQADV 8BM2 PHE B 836 UNP O60674 EXPRESSION TAG SEQADV 8BM2 GLN B 837 UNP O60674 EXPRESSION TAG SEQADV 8BM2 SER B 838 UNP O60674 EXPRESSION TAG SEQADV 8BM2 MET B 839 UNP O60674 EXPRESSION TAG SEQRES 1 A 317 MET GLY HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP SEQRES 2 A 317 LEU GLY THR GLU ASN LEU TYR PHE GLN SER MET ASP PRO SEQRES 3 A 317 THR GLN PHE GLU GLU ARG HIS LEU LYS PHE LEU GLN GLN SEQRES 4 A 317 LEU GLY LYS GLY ASN PHE GLY SER VAL GLU MET CYS ARG SEQRES 5 A 317 TYR ASP PRO LEU GLN ASP ASN THR GLY GLU VAL VAL ALA SEQRES 6 A 317 VAL LYS LYS LEU GLN HIS SER THR GLU GLU HIS LEU ARG SEQRES 7 A 317 ASP PHE GLU ARG GLU ILE GLU ILE LEU LYS SER LEU GLN SEQRES 8 A 317 HIS ASP ASN ILE VAL LYS TYR LYS GLY VAL CYS TYR SER SEQRES 9 A 317 ALA GLY ARG ARG ASN LEU LYS LEU ILE MET GLU TYR LEU SEQRES 10 A 317 PRO TYR GLY SER LEU ARG ASP TYR LEU GLN LYS HIS LYS SEQRES 11 A 317 GLU ARG ILE ASP HIS ILE LYS LEU LEU GLN TYR THR SER SEQRES 12 A 317 GLN ILE CYS LYS GLY MET GLU TYR LEU GLY THR LYS ARG SEQRES 13 A 317 TYR ILE HIS ARG ASP LEU ALA THR ARG ASN ILE LEU VAL SEQRES 14 A 317 GLU ASN GLU ASN ARG VAL LYS ILE GLY ASP PHE GLY LEU SEQRES 15 A 317 THR LYS VAL LEU PRO GLN ASP LYS GLU PTR PTR LYS VAL SEQRES 16 A 317 LYS GLU PRO GLY GLU SER PRO ILE PHE TRP TYR ALA PRO SEQRES 17 A 317 GLU SER LEU THR GLU SER LYS PHE SER VAL ALA SER ASP SEQRES 18 A 317 VAL TRP SER PHE GLY VAL VAL LEU TYR GLU LEU PHE THR SEQRES 19 A 317 TYR ILE GLU LYS SER LYS SER PRO PRO ALA GLU PHE MET SEQRES 20 A 317 ARG MET ILE GLY ASN ASP LYS GLN GLY GLN MET ILE VAL SEQRES 21 A 317 PHE HIS LEU ILE GLU LEU LEU LYS ASN ASN GLY ARG LEU SEQRES 22 A 317 PRO ARG PRO ASP GLY CYS PRO ASP GLU ILE TYR MET ILE SEQRES 23 A 317 MET THR GLU CYS TRP ASN ASN ASN VAL ASN GLN ARG PRO SEQRES 24 A 317 SER PHE ARG ASP LEU ALA LEU ARG VAL ASP GLN ILE ARG SEQRES 25 A 317 ASP ASN MET ALA GLY SEQRES 1 B 317 MET GLY HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP SEQRES 2 B 317 LEU GLY THR GLU ASN LEU TYR PHE GLN SER MET ASP PRO SEQRES 3 B 317 THR GLN PHE GLU GLU ARG HIS LEU LYS PHE LEU GLN GLN SEQRES 4 B 317 LEU GLY LYS GLY ASN PHE GLY SER VAL GLU MET CYS ARG SEQRES 5 B 317 TYR ASP PRO LEU GLN ASP ASN THR GLY GLU VAL VAL ALA SEQRES 6 B 317 VAL LYS LYS LEU GLN HIS SER THR GLU GLU HIS LEU ARG SEQRES 7 B 317 ASP PHE GLU ARG GLU ILE GLU ILE LEU LYS SER LEU GLN SEQRES 8 B 317 HIS ASP ASN ILE VAL LYS TYR LYS GLY VAL CYS TYR SER SEQRES 9 B 317 ALA GLY ARG ARG ASN LEU LYS LEU ILE MET GLU TYR LEU SEQRES 10 B 317 PRO TYR GLY SER LEU ARG ASP TYR LEU GLN LYS HIS LYS SEQRES 11 B 317 GLU ARG ILE ASP HIS ILE LYS LEU LEU GLN TYR THR SER SEQRES 12 B 317 GLN ILE CYS LYS GLY MET GLU TYR LEU GLY THR LYS ARG SEQRES 13 B 317 TYR ILE HIS ARG ASP LEU ALA THR ARG ASN ILE LEU VAL SEQRES 14 B 317 GLU ASN GLU ASN ARG VAL LYS ILE GLY ASP PHE GLY LEU SEQRES 15 B 317 THR LYS VAL LEU PRO GLN ASP LYS GLU PTR PTR LYS VAL SEQRES 16 B 317 LYS GLU PRO GLY GLU SER PRO ILE PHE TRP TYR ALA PRO SEQRES 17 B 317 GLU SER LEU THR GLU SER LYS PHE SER VAL ALA SER ASP SEQRES 18 B 317 VAL TRP SER PHE GLY VAL VAL LEU TYR GLU LEU PHE THR SEQRES 19 B 317 TYR ILE GLU LYS SER LYS SER PRO PRO ALA GLU PHE MET SEQRES 20 B 317 ARG MET ILE GLY ASN ASP LYS GLN GLY GLN MET ILE VAL SEQRES 21 B 317 PHE HIS LEU ILE GLU LEU LEU LYS ASN ASN GLY ARG LEU SEQRES 22 B 317 PRO ARG PRO ASP GLY CYS PRO ASP GLU ILE TYR MET ILE SEQRES 23 B 317 MET THR GLU CYS TRP ASN ASN ASN VAL ASN GLN ARG PRO SEQRES 24 B 317 SER PHE ARG ASP LEU ALA LEU ARG VAL ASP GLN ILE ARG SEQRES 25 B 317 ASP ASN MET ALA GLY MODRES 8BM2 PTR A 1007 TYR MODIFIED RESIDUE MODRES 8BM2 PTR A 1008 TYR MODIFIED RESIDUE MODRES 8BM2 PTR B 1007 TYR MODIFIED RESIDUE MODRES 8BM2 PTR B 1008 TYR MODIFIED RESIDUE HET PTR A1007 23 HET PTR A1008 23 HET PTR B1007 23 HET PTR B1008 23 HET QQC A1201 58 HET QQC B1201 58 HETNAM PTR O-PHOSPHOTYROSINE HETNAM QQC 3-[(4-CHLORANYL-2-FLUORANYL-PHENYL)METHYL]-2-METHYL- HETNAM 2 QQC ~{N}-(5-METHYL-1~{H}-PYRAZOL-3-YL)-8-(MORPHOLIN-4- HETNAM 3 QQC YLMETHYL)IMIDAZO[1,2-B]PYRIDAZIN-6-AMINE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 4(C9 H12 N O6 P) FORMUL 3 QQC 2(C23 H25 CL F N7 O) FORMUL 5 HOH *513(H2 O) HELIX 1 AA1 GLU A 845 ARG A 847 5 3 HELIX 2 AA2 THR A 888 LEU A 905 1 18 HELIX 3 AA3 TYR A 918 ARG A 923 1 6 HELIX 4 AA4 SER A 936 HIS A 944 1 9 HELIX 5 AA5 LYS A 945 ILE A 948 5 4 HELIX 6 AA6 ASP A 949 LYS A 970 1 22 HELIX 7 AA7 ALA A 978 ARG A 980 5 3 HELIX 8 AA8 PRO A 1017 TYR A 1021 5 5 HELIX 9 AA9 ALA A 1022 SER A 1029 1 8 HELIX 10 AB1 SER A 1032 TYR A 1050 1 19 HELIX 11 AB2 GLU A 1052 LYS A 1055 5 4 HELIX 12 AB3 SER A 1056 GLY A 1066 1 11 HELIX 13 AB4 GLY A 1071 ASN A 1084 1 14 HELIX 14 AB5 PRO A 1095 TRP A 1106 1 12 HELIX 15 AB6 ASN A 1109 ARG A 1113 5 5 HELIX 16 AB7 SER A 1115 MET A 1130 1 16 HELIX 17 AB8 GLU B 845 ARG B 847 5 3 HELIX 18 AB9 THR B 888 SER B 904 1 17 HELIX 19 AC1 TYR B 918 ARG B 923 1 6 HELIX 20 AC2 SER B 936 LYS B 945 1 10 HELIX 21 AC3 GLU B 946 ILE B 948 5 3 HELIX 22 AC4 ASP B 949 LYS B 970 1 22 HELIX 23 AC5 ALA B 978 ARG B 980 5 3 HELIX 24 AC6 ASP B 994 THR B 998 5 5 HELIX 25 AC7 PRO B 1017 TYR B 1021 5 5 HELIX 26 AC8 ALA B 1022 SER B 1029 1 8 HELIX 27 AC9 SER B 1032 TYR B 1050 1 19 HELIX 28 AD1 SER B 1056 GLY B 1066 1 11 HELIX 29 AD2 GLY B 1071 ASN B 1084 1 14 HELIX 30 AD3 PRO B 1095 TRP B 1106 1 12 HELIX 31 AD4 ASN B 1109 ARG B 1113 5 5 HELIX 32 AD5 SER B 1115 MET B 1130 1 16 SHEET 1 AA1 5 LEU A 849 GLY A 858 0 SHEET 2 AA1 5 GLY A 861 TYR A 868 -1 O MET A 865 N GLN A 853 SHEET 3 AA1 5 GLU A 877 LYS A 883 -1 O VAL A 881 N GLU A 864 SHEET 4 AA1 5 LYS A 926 GLU A 930 -1 O MET A 929 N ALA A 880 SHEET 5 AA1 5 TYR A 913 CYS A 917 -1 N GLY A 915 O ILE A 928 SHEET 1 AA2 2 TYR A 972 ILE A 973 0 SHEET 2 AA2 2 LYS A 999 VAL A1000 -1 O LYS A 999 N ILE A 973 SHEET 1 AA3 2 ILE A 982 ASN A 986 0 SHEET 2 AA3 2 ARG A 989 ILE A 992 -1 O LYS A 991 N LEU A 983 SHEET 1 AA4 2 PTR A1008 LYS A1009 0 SHEET 2 AA4 2 LYS A1030 PHE A1031 -1 O PHE A1031 N PTR A1008 SHEET 1 AA5 5 LEU B 849 GLY B 858 0 SHEET 2 AA5 5 GLY B 861 TYR B 868 -1 O VAL B 863 N LEU B 855 SHEET 3 AA5 5 GLU B 877 LYS B 883 -1 O GLU B 877 N TYR B 868 SHEET 4 AA5 5 LYS B 926 GLU B 930 -1 O MET B 929 N ALA B 880 SHEET 5 AA5 5 TYR B 913 CYS B 917 -1 N GLY B 915 O ILE B 928 SHEET 1 AA6 2 TYR B 972 ILE B 973 0 SHEET 2 AA6 2 LYS B 999 VAL B1000 -1 O LYS B 999 N ILE B 973 SHEET 1 AA7 2 ILE B 982 ASN B 986 0 SHEET 2 AA7 2 ARG B 989 ILE B 992 -1 O LYS B 991 N LEU B 983 SHEET 1 AA8 2 PTR B1008 LYS B1009 0 SHEET 2 AA8 2 LYS B1030 PHE B1031 -1 O PHE B1031 N PTR B1008 LINK C GLU A1006 N PTR A1007 1555 1555 1.33 LINK C PTR A1007 N PTR A1008 1555 1555 1.32 LINK C PTR A1008 N LYS A1009 1555 1555 1.34 LINK C GLU B1006 N PTR B1007 1555 1555 1.31 LINK C PTR B1007 N PTR B1008 1555 1555 1.32 LINK C PTR B1008 N LYS B1009 1555 1555 1.34 CRYST1 99.894 69.254 110.299 90.00 98.68 90.00 I 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010011 0.000000 0.001528 0.00000 SCALE2 0.000000 0.014440 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009171 0.00000